Figure 2

Comparison of survival curves between the antifibrotic and no-antifibrotic groups of patients with idiopathic pulmonary fibrosis. Kaplan–Meier survival curves are shown for the antifibrotic (solid line) and no-antifibrotic (dotted line) groups.